|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||
| Stock based compensation | |||||
| Depreciation and amortization | |||||
| Deferred loan and lease commission costs amortization | |||||
| Bad debt expense | |||||
| Straight-line rent | |||||
| Defined contribution plan income | |||||
| Impairment of real estate assets | |||||
| ERP implementation cost write off | |||||
| Interest receivable, related party write-off | |||||
| Unrealized gain on derivative instruments | |||||
| Changes in operating assets and liabilities: | |||||
| Accrued rent and accounts receivable | |||||
| Deferred leasing commissions costs | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable and accrued expenses | |||||
| Due to/from related parties | |||||
| Tenants' security deposits | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities: | |||||
| Acquisition deposits | |||||
| Investment in affiliate - related party | |||||
| Investment in other assets | |||||
| Note receivable - related party | |||||
| Additions to real estate | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Distributions to common stockholders | |||||
| Distributions to non-controlling interest | |||||
| Repayments to affiliates | |||||
| Borrowings from an affiliate | |||||
| Repayments under insurance premium finance note | |||||
| Borrowings under insurance premium finance note | |||||
| Repayments under term loan notes | |||||
| Borrowings under term loan notes | |||||
| Redemptions of common stock | |||||
| Payments of deferred loan costs | |||||
| Net cash provided by (used in) financing activities | |||||
| Net change in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
| Supplemental cash flow information: | |||||
| Cash paid for interest | |||||
| Supplemental disclosures of non-cash activities: | |||||
| Issuance of common stock in connection with the Mergers | |||||
| Issuance of Hartman XX OP units for 70% in Advisors | |||||
| Issuance of Hartman XX OP units for HIREIT OP units | |||||
| Notes conveyed to settle related party payable to Hartman XXI | |||||
| Value of Common shares issued to acquire non-controlling interest | |||||
| Acquisition of non-controlling interest | |||||
| Value of Director's stock compensation shares issued | |||||
| Reduction of interest payable from Hartman XXI settlement | |||||
| Decrease in interest payable from Hartman XXI settlement | |||||
| Decrease in due from related parties from Hartman XXI settlement | |||||
| Decrease in borrowing from affiliate from Hartman XXI settlement | |||||
| Increase of additions to real estate in accounts payable and accrued expenses | |||||
Loading...